Loading...

ALGS ALIGOS THERAPEUTICS INC Capital Structure Changes 8-K Filing

LGS

LGS

ALIGOS THERAPEUTICS INC

(ALGS)

2024 8-K

Show Summary

Show Summary

Equity Offerings

Earnings Releases

Financial Results

Securities Agreement

Management Change

Financial Results

Appointment of Directors

Resignation from Board

Resignation of CMO

Stock Option Exchange Program

Option Exchange Program

Resignation of President

Earnings Reports

Securities Purchase Agreement

Settlement Agreement with J...

Delisting Notice

Results of Operations and F...

Legal Proceedings Stipulation

Earnings Reports

Earnings Report

External Links:

Aligos Therapeutics executed a 1-for-25 reverse stock split effective August 19, 2024, to comply with Nasdaq listing requirements, converting every 25 shares into 1 share without altering shareholder rights.

AI Assistant

ALIGOS THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.